LONDON, August 26, 2010 /PRNewswire-FirstCall/ -- Hikma Pharmaceuticals
reports half year profit growth and raises gross margin guidance.
In a video interview on www.cantos.com, Hikma CEO Said Darwazah says a
good performance at the company's three divisions supported the results. "All
thre